Literature DB >> 3414543

Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction.

R B Kleiman1, J M Miller, A E Buxton, M E Josephson, F E Marchlinski.   

Abstract

Eighty-seven patients with sustained ventricular tachycardia (VT) between 3 and 90 days after acute myocardial infarction (AMI) were evaluated to define factors associated with a high risk of arrhythmia recurrence or death. Most patients had poor left ventricular function (mean ejection fraction 29 +/- 12%), multivessel coronary artery disease (71%) and inducible sustained VT with programmed stimulation (87%). During a mean follow-up of 26 months, 36 patients (41%) died and 21 patients had arrhythmia recurrence (with 19 sudden deaths). Factors independently associated with mortality included: (1) treatment before 1981 (p less than 0.01); (2) anterior AMI (p less than 0.05); (3) short time from AMI to first episode of VT (p less than 0.06); and (4) multivessel coronary artery disease (p less than 0.07). Factors independently associated with arrhythmia recurrence were: (1) medical treatment (as opposed to surgical) (p less than 0.01); (2) greater than or equal to 3 episodes of spontaneous VT (p = 0.01); (3) multivessel coronary disease (p less than 0.05); and (4) anterior AMI (p less than 0.07). Medically and surgically treated patients did not differ significantly in overall survival (49 vs 61%, respectively), although short-term (6 month) surgical survival improved from 31% during the first half of the study to 96% in the latter half (p less than 0.01). For patients with sustained VT early after AMI the risk of death and arrhythmia recurrence can be assessed based on clinical and angiographic characteristics; in addition, surgical treatment is associated with a lower incidence of arrhythmia recurrence than medical treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3414543     DOI: 10.1016/0002-9149(88)90649-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention.

Authors:  J R Timmer; N Breet; T Svilaas; J Haaksma; I C Van Gelder; F Zijlstra
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

2.  Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine.

Authors:  N Tsutsumi; H Mitamura; Y Okada; T Yoshimoto; T Sadanaga; I Furuno; S Ogawa
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

3.  Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.

Authors:  A Proclemer; D Facchin; D Vanuzzo; G A Feruglio
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.